# OnCo record neoantigen-mrna-vaccine (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/neoantigen-mrna-vaccine/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "neoantigen-mrna-vaccine" ;
  schema:name "Personalised neoantigen (mRNA) vaccines"@en ;
  schema:description "A vaccine made for one patient, encoding the unique mutations in their own tumour, to train the immune system to hunt it."@en ;
  schema:url <https://onco.cc/technologies/neoantigen-mrna-vaccine/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_vaccine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q2378309> ;
  schema:citation <https://en.wikipedia.org/wiki/Cancer_vaccine> ;
  onco:status "phase-3" ;
  onco:related <https://onco.cc/ideas/idea-neoantigen-immunogenicity-rules/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/rcc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/intismeran-autogene/>, <https://onco.cc/drugs/autogene-cevumeran/> ;
  onco:companies <https://onco.cc/companies/moderna/>, <https://onco.cc/companies/merck/>, <https://onco.cc/companies/biontech/>, <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/gritstone/>, <https://onco.cc/companies/serova/>, <https://onco.cc/companies/curevac/>, <https://onco.cc/companies/evaxion/>, <https://onco.cc/companies/gamgee/>, <https://onco.cc/companies/geneos-therapeutics/>, <https://onco.cc/companies/kernal-biologics/>, <https://onco.cc/companies/nykode-therapeutics/>, <https://onco.cc/companies/tarebio/>, <https://onco.cc/companies/transgene/>, <https://onco.cc/companies/echo-immune/>, <https://onco.cc/companies/jaime-leandro-foundation/>, <https://onco.cc/companies/invoke-bio/>, <https://onco.cc/companies/ubivac/> ;
  onco:terms <https://onco.cc/terms/neoantigen/> ;
  onco:trials <https://onco.cc/trials/interpath-001/> ;
  onco:dependsOn <https://onco.cc/technologies/wes-wgs/>, <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/plasmid-dna-manufacturing/>, <https://onco.cc/technologies/sterile-fill-finish/> .